Literature DB >> 16517070

Dopamine-D1 and delta-opioid receptors co-exist in rat striatal neurons.

L M Ambrose1, S M Gallagher, E M Unterwald, E J Van Bockstaele.   

Abstract

Cocaine's enhancement of dopaminergic neurotransmission in the mesolimbic pathway plays a critical role in the initial reinforcing properties of this drug. However, other neurotransmitter systems are also integral to the addiction process. A large body of data indicates that opioids and dopamine together mediate emotional and reinforced behaviors. In support of this, cocaine-mediated increases in activation of dopamine D1 receptors (D1R) results in a desensitization of delta-opioid receptor (DOR) signaling through adenylyl cyclase (AC) in striatal neurons. To further define cellular mechanisms underlying this effect, the subcellular distribution of DOR and D1R was examined in the rat dorsolateral striatum. Dual immunoperoxidase/gold-silver detection combined with electron microscopy was used to identify DOR and D1R immunoreactivities in the same section of tissue. Semi-quantitative analysis revealed that a subset of dendritic cellular profiles exhibited both DOR and D1R immunoreactivities. Of 198 randomly sampled D1R immunoreactive profiles, 43% contained DOR. Similarly of 165 DOR-labeled cellular profiles, 52% contained D1R. The present data provide ultrastructural evidence for co-existence between DOR and D1R in striatal neurons, suggesting a possible mechanism whereby D1R modulation may alter DOR function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517070     DOI: 10.1016/j.neulet.2006.02.027

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

3.  PKA and ERK1/2 are involved in dopamine D₁ receptor-induced heterologous desensitization of the δ opioid receptor.

Authors:  Wei Xu; Chongguang Chen; Jian-Guo Li; Kelly Dimattio; Yujun Wang; Ellen Unterwald; Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2013-04-26       Impact factor: 5.037

Review 4.  The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Authors:  Paul Klenowski; Michael Morgan; Selena E Bartlett
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 5.  Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.

Authors:  Wakako Fujita; Ivone Gomes; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

6.  Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens.

Authors:  Lisa M Ambrose-Lanci; Niluk B Peiris; Ellen M Unterwald; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2008-03-15       Impact factor: 3.252

7.  Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors.

Authors:  Changqing Xu; Sylvia Fitting
Journal:  Front Neurosci       Date:  2016-11-08       Impact factor: 4.677

8.  Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum.

Authors:  Ralph J A Oude Ophuis; Arjen J Boender; Andrea J van Rozen; Roger A H Adan
Journal:  Front Neuroanat       Date:  2014-03-26       Impact factor: 3.856

9.  Using iPSC-derived human DA neurons from opioid-dependent subjects to study dopamine dynamics.

Authors:  Yang Sheng; Emily Filichia; Elizabeth Shick; Kenzie L Preston; Karran A Phillips; Leslie Cooperman; Zhicheng Lin; Paul Tesar; Barry Hoffer; Yu Luo
Journal:  Brain Behav       Date:  2016-05-25       Impact factor: 2.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.